Cleanrooms

Aug 21, 2016 by in PHARMACY Comments Off on Cleanrooms

          When it is necessary to control the environment, specifications for parameters such as temperature, humidity, colony-forming units (CFUs), and particulates per cubic foot should be…

read more

Specifications

Aug 21, 2016 by in PHARMACY Comments Off on Specifications

  Inactive Ingredients (Excipients) Excipients are defined as ingredients added to the drug formulation for purposes other than the therapeutic or medicinally active effect. They are largely inert substances that…

read more

Site Master File (SMF) and Drug Master File (DMF)

Aug 21, 2016 by in PHARMACY Comments Off on Site Master File (SMF) and Drug Master File (DMF)

    Content of Site Master Files Chapter 1. General Information • Name, address, and company description (C.1.1): Includes a brief description of the company, relation to other sites, and…

read more

Traceability and Sourcing

Aug 21, 2016 by in PHARMACY Comments Off on Traceability and Sourcing

  GMP regulations place responsibility for ensuring the quality of the materials used to manufacture drug products squarely on the shoulders of the pharmaceutical company. The globalization of the pharmaceutical…

read more

Documents and Records Management

Aug 21, 2016 by in PHARMACY Comments Off on Documents and Records Management

  At the highest level of the documentation hierarchy in most companies sits the quality manual, which defines the corporate objectives related to quality and compliance. It establishes a figurative…

read more

Automated or Computerized Systems

Aug 21, 2016 by in PHARMACY Comments Off on Automated or Computerized Systems

  • Identifying the need. Will an automated or computerized system provide the best solution to the business problem? • Proposing solutions. Solutions can be technical (that is, the computer…

read more

Scale-up and Transfer Activities

Aug 21, 2016 by in PHARMACY Comments Off on Scale-up and Transfer Activities

  Hold-Time Studies As the name implies, a study must exist for every time lapse (that is, hold time) anticipated or intended to occur between any two API and drug…

read more

Raw Materials, Packaging, and Infrastructure for Product Development

Aug 21, 2016 by in PHARMACY Comments Off on Raw Materials, Packaging, and Infrastructure for Product Development

!DOCTYPE html PUBLIC “-//W3C//DTD XHTML 1.1//EN” “http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd”> Chapter 59: Raw Materials, Packaging, and Infrastructure for Product Development The United States Food and Drug Administration (FDA) provides guidance for raw materials,…

read more

New Product Development Studies and Reports

Aug 21, 2016 by in PHARMACY Comments Off on New Product Development Studies and Reports

!DOCTYPE html PUBLIC “-//W3C//DTD XHTML 1.1//EN” “http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd”> Chapter 60: New Product Development Studies and Reports Drug development is the process of taking a new chemical lead through the stages necessary…

read more
Get Clinical Tree app for offline access